No Detail Found!

Effect of Honey in Improving Breast Cancer Treatment and Gene Expression Modulation of MMPS and TIMPS in Triple-negative Breast Cancer Cells.

Author(s)
Rafa Almeer Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia
A Alqarni Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia: College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
S Alqattan King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
S Abdi Department of Biochemistry, College of Science, King Saud University, P.O. Box 22452, Zip Code 11495, Riyadh, Saudi Arabia
S Alarifi Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia
Z Hassan Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt
A Semlali Genome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia
Abstract
Breast cancer treatment by chemotherapy or radiotherapy is widely used but has serious side-effects. Thus, honey which is a natural substance has been extensively studied for its anticancer properties. However, its mechanism of action remains unclear. The present study evaluated the effect of two varieties of natural honey (Sidr and Wild) on a human breast adenocarcinoma (MDA-MB-231) cell line. The MDA-MB-231 cell lines were treated with Sidr honey (H1) and Wild honey (H2) for 6, 24, or 48 h followed by cell morphology evaluation. Cell viability was examined by MTT assay and gene expression of three tissue inhibitors of metalloproteinase (TIMPs) and two matrix metalloproteinase (MMPs) were measured by real-time PCR. All subgroups exhibited altered morphology with accelerated detachment compared to untreated cells. The MTT assay after 48 h revealed that treatment with H1 and H2, reduced cell viability by 48% and 91% respectively, compared to that of untreated cells. These results suggest that anticancer effect of Sidr and Wild honey corresponds to their ability to modulate gene expression of MMPs and TIMPs in MDA-MB-231 cell lines. Further investigations are required to understand the molecular mechanism of honey as an anticancer agent.
Publication Details
Page(s) 1999-2007
Published Journal: Pakistan Journal of Zoology, Volume: 50, Issue: 6, Year: 2018

Request the full text from PASTIC

Keywords
Sidr Honey, Wild honey, MMPs, TIMPs, Triple-negative breast cancer, Tissue inhibitors of metalloproteinase, Matrix metalloproteinase.
References
Abubakar , M.B.,Abdullah , W.Z.,Sulaiman , S.A.,Suen , A.B., 2012.A review of molecular mechanisms of the anti-leukemic effects of phenolic compounds in honey,Int. J. mol. Sci 13 15054 -15073
ACS, 2016.-andstatistics/annual-cancer-facts-and-figures/2016/ cancer-facts-and-figures-2016, -
Ahmed , S.,Othman , N.H., 2013.Honey as a potential natural anticancer agent: A review of its mechanisms,Evidence-Based Compl. Altern. Med 7 -
Ahmed , S.,Othman , N.H., 2013b.Review of the medicinal effects of tualang honey and a comparison with manuka honey,Malaysian J. med. Sci. 20 6 -13
Ahmed , S.,Othman , N.H., 2017.The anti-cancer effects of Tualang honey in modulating breast carcinogenesis: an experimental animal study,BMC Compl. Altern. Med 17 208 -
Al-Olayan , E.M.,El-Khadragy , M.F.,Aref , A.M.,Othman , M.S.,Kassab , R.B.,Abdel-Moneim , A.E., 2014.The potential protective effect of Physalis peruviana L. against carbon tetrachlorideinduced hepatotoxicity in rats is mediated by suppression of oxidative stress and downregulation of MMP-9 expression,Oxid. Med -
Baker , E.A.,Stephenson , T.J.,Reed , M.W.,Brown, 2002.Expression of proteinases and inhibitors in human breast cancer progression and survival,Mol. Pathol 55 300 -304
Benson , C.S.,Babu , S.D.,Radhakrishna , S.,Selvamurugan , N.,Ravi-Sankar , B., 2013.Expression of matrix metalloproteinases in human breast cancer tissues,Dis. Markers 34 395 -405
Brown, 1998.Matrix metalloproteinase inhibitors,Breast Cancer Res. Treat. 52 125 -136
Brummer , O.,Athar , S.,Riethdorf , L.,Loning , T.,Herbst, 1999.Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: An in situ hybridization study,Virchows Arch 435 566 -573
Chavez , K.J.,Garimella , S.V.,Lipkowitz , S., 2010.Triple negative breast cancer cell lines: One tool in the search for better treatment of triple negative breast cancer,Breast Dis 32 35 -48
Chung , T.W.,S.K. , Chang,Y.C. , Ko,J.H. , Lee,Y.C. , Cho,G. , Kim,S.H. , Kim,J.G. and Kim,C.H., 2004.Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: Complete regression of hepatoma growth and metastasis by dual mechanism, 18 2126com -1681
Deryugina , E.I.,Quigley , J.P., 2006.Matrix metalloproteinases and tumor metastasis,Cancer Metastasis Rev. 25 9 -34
Elmore , S., 2007.Apoptosis: A review of programmed cell death,Toxicol 35 495 -516
Erejuwa , O.O.,Sulaiman , S.A.,Wahab , M.S., 2014.Effects of honey and its mechanisms of action on the development and progression of cancer,Molecules 19 2497 -2522
Fauzi , A.N.,Norazmi , M.N.,Yaacob , N.S., 2010.Tualang honey induces apoptosis and disrupts the mitochondrial membrane potential of human breast and cervical cancer cell lines,Fd. Chem 12 871 -878
Gheldof , N.,Wang , X.H.,Engeseth , N.J., 2002.Identification and quantification of antioxidant components of honeys from various floral sources,J. Agric. Fd. Chem 50 5870 -5877
Hussein , S.Z.,Yusoff , M.K.,Makpol , S.,Yusof , M.Y.A., 2012.Gelam honey inhibits the production of proinflammatory, Mediators NO, TNF-α, and IL-6 in Carrageenan-induced acute paw edema in rats,Evidence-Based Compl. Altern. Med 13 -
Irvin,Carey , L.A., 2008.What is triplenegative breast cancer,Eur. J. Cancer 09 2799 -2805
Jaganathan , S.K.,Mandal , M., 2010.Involvement of non-protein thiols, mitochondrial dysfunction, reactive oxygen species and p53 in honey-induced apoptosis,Invest. New Drugs 28 624 -633
Jemal , A.,Bray , F.,Center , M.M.,Ferlay , J.,Ward , E.,Forman , D., 2011.,CA Cancer J. Clin. 61 69 -90
Klettner , A.K.,Kruse,Wesch , D.,Kabelitz , D.,Roider , J., 2009.Different properties of VEGF-antagonists: Bevacizumab but not Ranibizumab accumulates in RPE cells,Graefes Arch. Clin. Exp 247 1601 -1608
Lara-Medina , F.,Perez-Sanchez , V.,Saavedra-Perez , D.,Blake-Cerda , M.,Arce , C.,Motola-Kuba , D.,Villarreal-Garza , C.,Gonzalez-Angulo , A.M.,Bargallo , E.,Aguilar , J.L.,Mohar , A.,Arrieta , O., 2011.Triple-negative breast cancer in Hispanic patients: High prevalence, poor prognosis, and association with menopausal status, body mass index, and parity,Cancer 117 3658 -3669
Livak , K.J.,Schmittgen, 2001.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method, 25 402 -408
Martin , T.A.,Ye , L.,Sanders , A.J.,Lane , J.,JiangW.G., 2013.Madame Curie bioscience database,Landes Bioscience -
Medina , R.A.,Owen , G.I., 2002.Glucose transporters: Expression, regulation and cancer,Biol. Res. 35 9 -26
Mijanur-Rahman , M.,Gan , S.H.,Khalil , M.I., 2014.Neurological effects of honey: Current and future prospects,Evidance-Based Compl. Altern. Med 958721 -
Pichichero , E.,Cicconi , R.,Mattei , M.,Muzi , M.G.,Canini , A., 2010.Acacia honey and chrysin reduce proliferation of melanoma cells through alterations in cell cycle progression,Int. J. Oncol. 37 973 -981
Porcza , L.M.,Simms , C.,Chopra , M., 2016.Honey and cancer: Current status and future directions,Diseases 4 E30 -
Radisky , E.S.,Radisky , D.C., 2015.Matrix metalloproteinases as breast cancer drivers and therapeutic targets,Front 20 1144 -1163
Roy , R.,Yang , J.,Moses , M.A., 2009.Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer,J. clin. Oncol 23 5287 -5297
Saxena , S.,Gautam , S.,Maru , G.,Kawle , D.,Sharma , A., 2012.Suppression of error prone pathway is responsible for antimutagenic activity of honey,Fd. Chem 01 625 -633
Semlali , A.,Jalouli , M.,Parine , N.R.,Al-Amri , A.,Arafah , M.,Al-Naeem , A.,Abdullah , A.S.,Rouabhia , M.,Alanazi , M.S., 2017.Toll-like receptor 4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women,Onco Targets Ther. 10 1207 -1216
Sergiel , I.,Pohl , P.,Biesaga , M., 2013.Characterisation of honeys according to their content of phenolic compounds using high performance liquid chromatography/tandem mass spectrometry,Fd. Chem 08 404 -408
Shimoda , M.,Principe , S.,Jackson , H.W.,Luga , V.,Fang , H.,Molyneux , S.D.,Shao , Y.W.,Aiken , A.,Waterhouse , P.D.,Karamboulas , C.,Hess , F.M.,Ohtsuka , T.,Okada , Y.,Ailles , L.,Ludwig , A.,Wrana , J.L.,Kislinger , T.,Khokha , R., 2014.Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state,Nat. Cell Biol 16 889 -901
Stamenkovic , I., 2000.Matrix metalloproteinases in tumor invasion and metastasis,Semin. Cancer Biol 10 415 -433
Sun , J., 2010.Matrix metalloproteinases and tissue inhibitor of metalloproteinases are essential for the inflammatory response in cancer cells,J. Signal Transduct -
Tsiapara , A.V.,Jaakkola , M.,Chinou , I.,Graikou , K.,Tolonen , T.,Virtanen , V.,Moutsatsou , P., 2009.Bioactivity of Greek honey extracts on breast cancer (MCF-7), prostate cancer (PC-3) and endometrial cancer (Ishikawa) cells: Profile analysis of extracts,Fd. Chem 03 702 -708
van der Woude,Gliszczynska-Swiglo , A.,Struijs , K.,Smeets , A.,Alink , G.M.,Rietjens , I.M., 2003.Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans,Cancer Lett. 3835 00412 -9
van't Veer , L.J.,Dai , H., van de Vijver, M.J.,He , Y.D.,Hart , A.A.M.,Mao , M.,Peterse,van der Kooy , K.,Marton , M.J.,Witteveen , A.T.,Schreiber , G.J.,Kerkhoven , R.M.,Roberts , C.,Linsley , P.S.,Bernards , R.,Friend , S.H., 2002.Gene expression profiling predicts clinical outcome of breast cancer,Nature 415 530 -
Vaz-Luis , I.,Ottesen , R.A.,Hughes , M.E.,Mamet , R.,Burstein , H.J.,Edge , S.B.,Gonzalez-Angulo , A.M.,Moy , B.,Rugo , H.S.,Theriault , R.L.,Weeks , J.C.,Winer , E.P.,Lin , N.U., 2013.Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: A multiinstitutional study,J. clin. Oncol 53 2142 -2150
Yu , A.F.,Jones , L.W., 2016.Breast cancer treatmentassociated cardiovascular toxicity and effects of exercise countermeasures,Cardio-Oncology 2 -
0

Citations

0

Downloads

93

Views